285 related articles for article (PubMed ID: 34508355)
1. TARG1 protects against toxic DNA ADP-ribosylation.
Tromans-Coia C; Sanchi A; Moeller GK; Timinszky G; Lopes M; Ahel I
Nucleic Acids Res; 2021 Oct; 49(18):10477-10492. PubMed ID: 34508355
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for DarT ADP-ribosylation of a DNA base.
Schuller M; Butler RE; Ariza A; Tromans-Coia C; Jankevicius G; Claridge TDW; Kendall SL; Goh S; Stewart GR; Ahel I
Nature; 2021 Aug; 596(7873):597-602. PubMed ID: 34408320
[TBL] [Abstract][Full Text] [Related]
3.
Hloušek-Kasun A; Mikolčević P; Rack JGM; Tromans-Coia C; Schuller M; Jankevicius G; Matković M; Bertoša B; Ahel I; Mikoč A
Comput Struct Biotechnol J; 2022; 20():4337-4350. PubMed ID: 36051881
[TBL] [Abstract][Full Text] [Related]
4. Reversible mono-ADP-ribosylation of DNA breaks.
Munnur D; Ahel I
FEBS J; 2017 Dec; 284(23):4002-4016. PubMed ID: 29054115
[TBL] [Abstract][Full Text] [Related]
5. Reversible ADP-ribosylation of RNA.
Munnur D; Bartlett E; Mikolčević P; Kirby IT; Rack JGM; Mikoč A; Cohen MS; Ahel I
Nucleic Acids Res; 2019 Jun; 47(11):5658-5669. PubMed ID: 31216043
[TBL] [Abstract][Full Text] [Related]
6. The Toxin-Antitoxin System DarTG Catalyzes Reversible ADP-Ribosylation of DNA.
Jankevicius G; Ariza A; Ahel M; Ahel I
Mol Cell; 2016 Dec; 64(6):1109-1116. PubMed ID: 27939941
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar-nucleoplasmic shuttling of TARG1 and its control by DNA damage-induced poly-ADP-ribosylation and by nucleolar transcription.
Bütepage M; Preisinger C; von Kriegsheim A; Scheufen A; Lausberg E; Li J; Kappes F; Feederle R; Ernst S; Eckei L; Krieg S; Müller-Newen G; Rossetti G; Feijs KLH; Verheugd P; Lüscher B
Sci Rep; 2018 Apr; 8(1):6748. PubMed ID: 29712969
[TBL] [Abstract][Full Text] [Related]
8. DNA ADP-Ribosylation Stalls Replication and Is Reversed by RecF-Mediated Homologous Recombination and Nucleotide Excision Repair.
Lawarée E; Jankevicius G; Cooper C; Ahel I; Uphoff S; Tang CM
Cell Rep; 2020 Feb; 30(5):1373-1384.e4. PubMed ID: 32023456
[TBL] [Abstract][Full Text] [Related]
9. The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies.
Catara G; Caggiano R; Palazzo L
Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839512
[TBL] [Abstract][Full Text] [Related]
10. The interplay of TARG1 and PARG protects against genomic instability.
Groslambert J; Prokhorova E; Wondisford AR; Tromans-Coia C; Giansanti C; Jansen J; Timinszky G; Dobbelstein M; Ahel D; O'Sullivan RJ; Ahel I
Cell Rep; 2023 Sep; 42(9):113113. PubMed ID: 37676774
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for the reversible ADP-ribosylation of guanosine bases.
Schuller M; Raggiaschi R; Mikolcevic P; Rack JGM; Ariza A; Zhang Y; Ledermann R; Tang C; Mikoc A; Ahel I
Mol Cell; 2023 Jul; 83(13):2303-2315.e6. PubMed ID: 37390817
[TBL] [Abstract][Full Text] [Related]
12. Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases.
Rosenthal F; Feijs KL; Frugier E; Bonalli M; Forst AH; Imhof R; Winkler HC; Fischer D; Caflisch A; Hassa PO; Lüscher B; Hottiger MO
Nat Struct Mol Biol; 2013 Apr; 20(4):502-7. PubMed ID: 23474714
[TBL] [Abstract][Full Text] [Related]
13. Deregulated DNA ADP-ribosylation impairs telomere replication.
Wondisford AR; Lee J; Lu R; Schuller M; Groslambert J; Bhargava R; Schamus-Haynes S; Cespedes LC; Opresko PL; Pickett HA; Min J; Ahel I; O'Sullivan RJ
Nat Struct Mol Biol; 2024 May; 31(5):791-800. PubMed ID: 38714889
[TBL] [Abstract][Full Text] [Related]
14. ADP-ribosylation of RNA and DNA: from in vitro characterization to in vivo function.
Weixler L; Schäringer K; Momoh J; Lüscher B; Feijs KLH; Žaja R
Nucleic Acids Res; 2021 Apr; 49(7):3634-3650. PubMed ID: 33693930
[TBL] [Abstract][Full Text] [Related]
15. Specificity of DNA ADP-Ribosylation Reversal by NADARs.
Cihlova B; Lu Y; Mikoč A; Schuller M; Ahel I
Toxins (Basel); 2024 Apr; 16(5):. PubMed ID: 38787060
[TBL] [Abstract][Full Text] [Related]
16. ENPP1 processes protein ADP-ribosylation in vitro.
Palazzo L; Daniels CM; Nettleship JE; Rahman N; McPherson RL; Ong SE; Kato K; Nureki O; Leung AK; Ahel I
FEBS J; 2016 Sep; 283(18):3371-88. PubMed ID: 27406238
[TBL] [Abstract][Full Text] [Related]
17. Back to the Roots: Deep View into the Evolutionary History of ADP-Ribosylation Opened by the DNA-Targeting Toxin-Antitoxin Module DarTG.
Harms A; Gerdes K
Mol Cell; 2016 Dec; 64(6):1020-1021. PubMed ID: 27984742
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease.
Sharifi R; Morra R; Appel CD; Tallis M; Chioza B; Jankevicius G; Simpson MA; Matic I; Ozkan E; Golia B; Schellenberg MJ; Weston R; Williams JG; Rossi MN; Galehdari H; Krahn J; Wan A; Trembath RC; Crosby AH; Ahel D; Hay R; Ladurner AG; Timinszky G; Williams RS; Ahel I
EMBO J; 2013 May; 32(9):1225-37. PubMed ID: 23481255
[TBL] [Abstract][Full Text] [Related]
19. SnapShot: ADP-Ribosylation Signaling.
Hottiger MO
Mol Cell; 2015 Jun; 58(6):1134-1134.e1. PubMed ID: 26091348
[TBL] [Abstract][Full Text] [Related]
20. Expanding functions of intracellular resident mono-ADP-ribosylation in cell physiology.
Feijs KL; Verheugd P; Lüscher B
FEBS J; 2013 Aug; 280(15):3519-29. PubMed ID: 23639026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
